Painreform is trading at $0.97 (-5.34%), with no clear company-specific catalyst identified.

  • Painreform declined 14.17% to $1.03 on August 14, 2026.
  • No recent press releases, filings, earnings release, or overnight catalyst were identified for August 17, 2026.
  • Broader markets are only slightly weaker and do not clearly explain the move, suggesting continued volatility rather than a confirmed fundamental trigger.